To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Accordion to buy Merilytics, as PE firms turn to value creation
'Much of the work in private equity has shifted to portfolio company improvement,' says Michael Choe, CEO of Charlesbank, which invested in Accordion in September.
